{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:54:05Z","timestamp":1789520045100,"version":"build-2803163510"},"reference-count":151,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Science and Technology plan project of the First People' s Hospital of Yunnan Province","award":["2024-KHRCBZ-B15"],"award-info":[{"award-number":["2024-KHRCBZ-B15"]}]},{"name":"Science and Technology plan project of the First People' s Hospital of Yunnan Province","award":["2024-KHRCBZ-B08"],"award-info":[{"award-number":["2024-KHRCBZ-B08"]}]},{"name":"Yunnan Fundamental Research Projects","award":["202401AU070048"],"award-info":[{"award-number":["202401AU070048"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460150"],"award-info":[{"award-number":["82460150"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nat Med"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s11418-025-01968-6","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T16:47:12Z","timestamp":1771519632000},"page":"249-268","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Salvia miltiorrhiza (Danshen) and its extracts in the alternative treatment of diabetic nephropathy: mechanisms and clinical perspectives"],"prefix":"10.1007","volume":"80","author":[{"given":"Lu","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huakui","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7326-204X","authenticated-orcid":false,"given":"Qinyuan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"issue":"1","key":"1968_CR1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","volume":"10","author":"MAB Khan","year":"2020","unstructured":"Khan MAB, Hashim MJ, King JK et al (2020) Epidemiology of type 2 diabetes\u2014global burden of disease and forecasted trends. J Epidemiol Glob Health 10(1):107\u2013111","journal-title":"J Epidemiol Glob Health"},{"key":"1968_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111857","author":"PH Hung","year":"2021","unstructured":"Hung PH, Hsu YC, Chen TH et al (2021) Recent advances in diabetic kidney diseases: from kidney injury to kidney fibrosis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms222111857","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1968_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1053\/j.ackd.2017.10.011","volume":"25","author":"DN Koye","year":"2018","unstructured":"Koye DN, Magliano DJ, Nelson RG et al (2018) The global epidemiology of diabetes and kidney disease. Adv Chronic Kidney Dis 25(2):121\u2013132","journal-title":"Adv Chronic Kidney Dis"},{"issue":"6","key":"1968_CR4","doi-asserted-by":"publisher","first-page":"960","DOI":"10.2174\/1874467214999210111222918","volume":"14","author":"Z Yin","year":"2021","unstructured":"Yin Z, Wang X, Yang X et al (2021) Salvia miltiorrhiza in anti-diabetic angiopathy. Curr Mol Pharmacol 14(6):960\u2013974","journal-title":"Curr Mol Pharmacol"},{"issue":"3","key":"1968_CR5","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/ndt\/gft321","volume":"29","author":"F Verbeke","year":"2014","unstructured":"Verbeke F, Lindley E, Van Bortel L et al (2014) A European renal best practice (ERBP) position statement on the Kidney disease: Improving global outcomes (KDIGO) clinical practice guideline for the management of blood pressure in non-dialysis-dependent chronic kidney disease: an endorsement with some caveats for real-life application. Nephrol Dial Transplant 29(3):490\u2013496","journal-title":"Nephrol Dial Transplant"},{"key":"1968_CR6","doi-asserted-by":"publisher","first-page":"1354950","DOI":"10.3389\/fendo.2024.1354950","volume":"15","author":"D Zhou","year":"2024","unstructured":"Zhou D, Zhou T, Tang S et al (2024) Network pharmacology combined with Mendelian randomization analysis to identify the key targets of renin-angiotensin-aldosterone system inhibitors in the treatment of diabetic nephropathy. Front Endocrinol (Lausanne) 15:1354950","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"1968_CR7","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1016\/j.apsb.2020.12.020","volume":"11","author":"G Tang","year":"2021","unstructured":"Tang G, Li S, Zhang C et al (2021) Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management. Acta Pharm Sin B 11(9):2749\u20132767","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"1968_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13020-024-00908-y","volume":"19","author":"P Zhai","year":"2024","unstructured":"Zhai P, Chen Q, Wang X et al (2024) The combination of Tanshinone IIA and Astragaloside IV attenuates myocardial ischemia-reperfusion injury by inhibiting the STING pathway. Chin Med 19(1):34","journal-title":"Chin Med"},{"key":"1968_CR9","doi-asserted-by":"publisher","first-page":"173352","DOI":"10.1016\/j.ejphar.2020.173352","volume":"883","author":"L Jiang","year":"2020","unstructured":"Jiang L, Wang J, Ju J et al (2020) Salvianolic acid B and sodium tanshinone II A sulfonate prevent pulmonary fibrosis through anti-inflammatory and anti-fibrotic process. Eur J Pharmacol 883:173352","journal-title":"Eur J Pharmacol"},{"issue":"42","key":"1968_CR10","doi-asserted-by":"publisher","first-page":"22288","DOI":"10.1074\/jbc.M115.712703","volume":"291","author":"P Wu","year":"2016","unstructured":"Wu P, Yan Y, Ma LL et al (2016) Effects of the Nrf2 protein modulator salvianolic acid A alone or combined with metformin on diabetes-associated macrovascular and renal injury. J Biol Chem 291(42):22288\u201322301","journal-title":"J Biol Chem"},{"key":"1968_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.120032","volume":"350","author":"T Lan","year":"2025","unstructured":"Lan T, Yu D, Zhao Q et al (2025) Ethnomedicine, phytochemistry, pharmacology, pharmacokinetics, and clinical application of Salvia miltiorrhiza Bunge (Lamiaceae): a comprehensive review [J]. J Ethnopharmacol 350:120032","journal-title":"J Ethnopharmacol"},{"issue":"Pt 3","key":"1968_CR12","doi-asserted-by":"publisher","first-page":"117354","DOI":"10.1016\/j.jep.2023.117354","volume":"319","author":"L Cai","year":"2024","unstructured":"Cai L, Chen Y, Xue H et al (2024) Effect and pharmacological mechanism of Salvia miltiorrhiza and its characteristic extracts on diabetic nephropathy. J Ethnopharmacol 319(Pt 3):117354","journal-title":"J Ethnopharmacol"},{"issue":"6865","key":"1968_CR13","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"M Brownlee","year":"2001","unstructured":"Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414(6865):813\u2013820","journal-title":"Nature"},{"issue":"6","key":"1968_CR14","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.2337\/db08-0057","volume":"57","author":"JM Forbes","year":"2008","unstructured":"Forbes JM, Coughlan MT, Cooper ME (2008) Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 57(6):1446\u20131454","journal-title":"Diabetes"},{"issue":"1","key":"1968_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/13813455.2020.1797106","volume":"129","author":"K Parwani","year":"2023","unstructured":"Parwani K, Mandal P (2023) Role of advanced glycation end products and insulin resistance in diabetic nephropathy. Arch Physiol Biochem 129(1):95\u2013107","journal-title":"Arch Physiol Biochem"},{"issue":"10","key":"1968_CR16","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.2337\/diabetes.52.10.2603","volume":"52","author":"M Kitada","year":"2003","unstructured":"Kitada M, Koya D, Sugimoto T et al (2003) Translocation of glomerular p47phox and p67phox by protein kinase C-beta activation is required for oxidative stress in diabetic nephropathy. Diabetes 52(10):2603\u20132614","journal-title":"Diabetes"},{"issue":"1","key":"1968_CR17","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/biom5010194","volume":"5","author":"K Nowotny","year":"2015","unstructured":"Nowotny K, Jung T, Hohn A et al (2015) Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules 5(1):194\u2013222","journal-title":"Biomolecules"},{"issue":"7","key":"1968_CR18","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1172\/JCI18127","volume":"112","author":"X Du","year":"2003","unstructured":"Du X, Matsumura T, Edelstein D et al (2003) Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest 112(7):1049\u20131057","journal-title":"J Clin Invest"},{"issue":"9","key":"1968_CR19","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1007\/s11255-020-02545-4","volume":"52","author":"EAT Koch","year":"2020","unstructured":"Koch EAT, Nakhoul R, Nakhoul F et al (2020) Autophagy in diabetic nephropathy: a review. Int Urol Nephrol 52(9):1705\u20131712","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"1968_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/boc.201800077","volume":"111","author":"M Szrejder","year":"2019","unstructured":"Szrejder M, Piwkowska A (2019) AMPK signalling: implications for podocyte biology in diabetic nephropathy. Biol Cell 111(5):109\u2013120","journal-title":"Biol Cell"},{"key":"1968_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/1497449","volume":"2021","author":"N Samsu","year":"2021","unstructured":"Samsu N (2021) Diabetic nephropathy: challenges in pathogenesis, diagnosis, and treatment. Biomed Res Int 2021:1497449","journal-title":"Biomed Res Int"},{"issue":"8","key":"1968_CR22","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1007\/s00125-016-4021-5","volume":"59","author":"FC Brosius","year":"2016","unstructured":"Brosius FC, Tuttle KR, Kretzler M (2016) JAK inhibition in the treatment of diabetic kidney disease. Diabetologia 59(8):1624\u20131627","journal-title":"Diabetologia"},{"issue":"2","key":"1968_CR23","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2337\/db08-1328","volume":"58","author":"CC Berthier","year":"2009","unstructured":"Berthier CC, Zhang H, Schin M et al (2009) Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy. Diabetes 58(2):469\u2013477","journal-title":"Diabetes"},{"issue":"5","key":"1968_CR24","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.bbagen.2011.03.014","volume":"1820","author":"S Yamagishi","year":"2012","unstructured":"Yamagishi S, Maeda S, Matsui T et al (2012) Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes. Biochim Biophys Acta 1820(5):663\u2013671","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"1968_CR25","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1111\/jcmm.16165","volume":"25","author":"Y Liang","year":"2021","unstructured":"Liang Y, Liu H, Fang Y et al (2021) Salvianolate ameliorates oxidative stress and podocyte injury through modulation of NOX4 activity in db\/db mice. J Cell Mol Med 25(2):1012\u20131023","journal-title":"J Cell Mol Med"},{"key":"1968_CR26","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev.immunol.021908.132532","volume":"27","author":"FO Martinez","year":"2009","unstructured":"Martinez FO, Helming L, Gordon S (2009) Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 27:451\u201383","journal-title":"Annu Rev Immunol"},{"key":"1968_CR27","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3389\/fimmu.2014.00614","volume":"5","author":"N Wang","year":"2014","unstructured":"Wang N, Liang H, Zen K (2014) Molecular mechanisms that influence the macrophage m1\u2013m2 polarization balance. Front Immunol 5:614","journal-title":"Front Immunol"},{"issue":"2","key":"1968_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054016","volume":"8","author":"W Hofkens","year":"2013","unstructured":"Hofkens W, Schelbergen R, Storm G et al (2013) Liposomal targeting of prednisolone phosphate to synovial lining macrophages during experimental arthritis inhibits M1 activation but does not favor M2 differentiation. PLoS ONE 8(2):e54016","journal-title":"PLoS ONE"},{"issue":"12","key":"1968_CR29","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/nri1733","volume":"5","author":"S Gordon","year":"2005","unstructured":"Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5(12):953\u2013964","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"1968_CR30","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","volume":"44","author":"TA Wynn","year":"2016","unstructured":"Wynn TA, Vannella KM (2016) Macrophages in tissue repair, regeneration, and fibrosis. Immunity 44(3):450\u2013462","journal-title":"Immunity"},{"key":"1968_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197057","author":"J Lin","year":"2020","unstructured":"Lin J, Cheng A, Cheng K et al (2020) New insights into the mechanisms of pyroptosis and implications for diabetic kidney disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21197057","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1968_CR32","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1681\/ASN.2004070612","volume":"16","author":"FY Chow","year":"2005","unstructured":"Chow FY, Nikolic-Paterson DJ, Ozols E et al (2005) Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db\/db mice. J Am Soc Nephrol 16(6):1711\u20131722","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"1968_CR33","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1073\/pnas.0611192104","volume":"104","author":"M Kato","year":"2007","unstructured":"Kato M, Zhang J, Wang M et al (2007) Microrna-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci U S A 104(9):3432\u20133437","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1968_CR34","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1681\/ASN.2009050530","volume":"21","author":"A Krupa","year":"2010","unstructured":"Krupa A, Jenkins R, Luo DD et al (2010) Loss of microRNA-192 promotes fibrogenesis in diabetic nephropathy. J Am Soc Nephrol 21(3):438\u2013447","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"1968_CR35","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1042\/CS20150427","volume":"129","author":"AD Mcclelland","year":"2015","unstructured":"Mcclelland AD, Herman-Edelstein M, Komers R et al (2015) MiR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7. Clin Sci (Lond) 129(12):1237\u20131249","journal-title":"Clin Sci (Lond)"},{"issue":"3","key":"1968_CR36","doi-asserted-by":"publisher","first-page":"147916412311721","DOI":"10.1177\/14791641231172139","volume":"20","author":"B Chen","year":"2023","unstructured":"Chen B, He Q (2023) miR-1187 induces podocyte injury and diabetic nephropathy through autophagy. Diab Vasc Dis Res 20(3):14791641231172140","journal-title":"Diab Vasc Dis Res"},{"issue":"3","key":"1968_CR37","doi-asserted-by":"publisher","first-page":"525","DOI":"10.12998\/wjcc.v12.i3.525","volume":"12","author":"D Shrivastav","year":"2024","unstructured":"Shrivastav D, Singh DD (2024) Emerging roles of microRNAs as diagnostics and potential therapeutic interest in type 2 diabetes mellitus. World J Clin Cases 12(3):525\u2013537","journal-title":"World J Clin Cases"},{"key":"1968_CR38","doi-asserted-by":"publisher","first-page":"5773","DOI":"10.2147\/DDDT.S257734","volume":"14","author":"S Xu","year":"2020","unstructured":"Xu S, He L, Ding K et al (2020) Tanshinone IIA Ameliorates Streptozotocin-Induced Diabetic Nephropathy, Partly by Attenuating PERK Pathway-Induced Fibrosis. Drug Des Devel Ther 14:5773\u201382","journal-title":"Drug Des Devel Ther"},{"issue":"9","key":"1968_CR39","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/nm.3902","volume":"21","author":"S Lovisa","year":"2015","unstructured":"Lovisa S, Lebleu VS, Tampe B et al (2015) Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis. Nat Med 21(9):998\u20131009","journal-title":"Nat Med"},{"issue":"7841","key":"1968_CR40","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41586-020-2941-1","volume":"589","author":"C Kuppe","year":"2021","unstructured":"Kuppe C, Ibrahim MM, Kranz J et al (2021) Decoding myofibroblast origins in human kidney fibrosis. Nature 589(7841):281\u2013286","journal-title":"Nature"},{"issue":"4","key":"1968_CR41","doi-asserted-by":"publisher","first-page":"F926","DOI":"10.1152\/ajprenal.00118.2017","volume":"313","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, Cai T, Xu J et al (2017) UCP2 attenuates apoptosis of tubular epithelial cells in renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 313(4):F926\u2013F937","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"1968_CR42","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1681\/ASN.2018040440","volume":"30","author":"M Mukherjee","year":"2019","unstructured":"Mukherjee M, Deriso J, Otterpohl K et al (2019) Endogenous Notch signaling in adult kidneys maintains segment-specific epithelial cell types of the distal tubules and collecting ducts to ensure water homeostasis. J Am Soc Nephrol 30(1):110\u2013126","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"1968_CR43","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.1681\/ASN.2017020130","volume":"28","author":"SH Han","year":"2017","unstructured":"Han SH, Wu MY, Nam BY et al (2017) PGC-1alpha protects from notch-induced kidney fibrosis development. J Am Soc Nephrol 28(11):3312\u20133322","journal-title":"J Am Soc Nephrol"},{"issue":"Pt 1","key":"1968_CR44","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1042\/BST0370232","volume":"37","author":"YY Chang","year":"2009","unstructured":"Chang YY, JUH\u00e1SZ G, Goraksha-Hicks P et al (2009) Nutrient-dependent regulation of autophagy through the target of rapamycin pathway. Biochem Soc Trans 37(Pt 1):232\u2013236","journal-title":"Biochem Soc Trans"},{"key":"1968_CR45","doi-asserted-by":"publisher","first-page":"917773","DOI":"10.3389\/fendo.2022.917773","volume":"13","author":"J Yan","year":"2022","unstructured":"Yan J, Wang J, He JC et al (2022) Sirtuin 1 in chronic kidney disease and therapeutic potential of targeting sirtuin 1. Front Endocrinol (Lausanne) 13:917773","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"1968_CR46","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrneph.2016.75","volume":"12","author":"VD D'agati","year":"2016","unstructured":"D\u2019agati VD, Chagnac A, De Vries AP et al (2016) Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nat Rev Nephrol 12(8):453\u2013471","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"1968_CR47","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nrneph.2014.87","volume":"10","author":"A Fornoni","year":"2014","unstructured":"Fornoni A, Merscher S, Kopp JB (2014) Lipid biology of the podocyte\u2013new perspectives offer new opportunities. Nat Rev Nephrol 10(7):379\u2013388","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"1968_CR48","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1172\/JCI125316","volume":"129","author":"GM Ducasa","year":"2019","unstructured":"Ducasa GM, Mitrofanova A, Mallela SK et al (2019) ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes. J Clin Invest 129(8):3387\u20133400","journal-title":"J Clin Invest"},{"issue":"6","key":"1968_CR49","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.cmet.2020.10.019","volume":"32","author":"Y Fu","year":"2020","unstructured":"Fu Y, Sun Y, Wang M et al (2020) Elevation of JAML Promotes Diabetic Kidney Disease by Modulating Podocyte Lipid Metabolism. Cell Metab 32(6):1052\u201362 e8","journal-title":"Cell Metab"},{"issue":"11","key":"1968_CR50","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/nrneph.2017.129","volume":"13","author":"AV Cybulsky","year":"2017","unstructured":"Cybulsky AV (2017) Endoplasmic reticulum stress, the unfolded protein response and autophagy in kidney diseases [J]. Nat Rev Nephrol 13(11):681\u2013696","journal-title":"Nat Rev Nephrol"},{"issue":"1\u20132","key":"1968_CR51","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11010-015-2567-z","volume":"411","author":"Y Xu","year":"2016","unstructured":"Xu Y, Wang J, Pan T et al (2016) Role of the ER stress in prostaglandin E2\/E-prostanoid 2 receptor involved TGF-beta1-induced mice mesangial cell injury [J]. Mol Cell Biochem 411(1\u20132):43\u201355","journal-title":"Mol Cell Biochem"},{"key":"1968_CR52","doi-asserted-by":"crossref","unstructured":"WANG X, ZHAO J, LI Y, et al. Epigenetics and endoplasmic reticulum in podocytopathy during diabetic nephropathy progression [J]. Front Immunol, 2022, 13(1090989.","DOI":"10.3389\/fimmu.2022.1090989"},{"issue":"10","key":"1968_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105145","volume":"25","author":"N Zang","year":"2022","unstructured":"Zang N, Cui C, Guo X et al (2022) cGAS-STING activation contributes to podocyte injury in diabetic kidney disease. iScience 25(10):105145","journal-title":"iScience"},{"key":"1968_CR54","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.174126","author":"S Khedr","year":"2024","unstructured":"Khedr S, Dissanayake LV, Alsheikh AJ et al (2024) Role of cGAS\/STING pathway in aging and sexual dimorphism in diabetic kidney disease. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.174126","journal-title":"JCI Insight"},{"key":"1968_CR55","doi-asserted-by":"crossref","unstructured":"YUN J, SHAN J, LI J. Targeting the TFAM-cGAS-STING axis: a mitochondrial-inflammatory link in the pathogenesis and treatment of diabetic kidney disease [J]. Int Urol Nephrol, 2025,","DOI":"10.1007\/s11255-025-04651-7"},{"key":"1968_CR56","doi-asserted-by":"crossref","unstructured":"XU Z, XIANG X, SU S, et al. Multi-omics analysis reveals the pathogenesis of db\/db mice diabetic kidney disease and the treatment mechanisms of multi-bioactive compounds combination from Salvia miltiorrhiza [J]. Front Pharmacol, 2022, 13:987668.","DOI":"10.3389\/fphar.2022.987668"},{"key":"1968_CR57","unstructured":"MAXIAOJING, JIAN Y, MAGUIRONG, et al. Research Progress on modernization of traditional Chinese medicine Salvia miltiorrhiza [J]. Chinese Journal of traditional Chinese Medicine, 2022, 47(19): 5131\u20139."},{"key":"1968_CR58","unstructured":"CHENZEQI, QUHAIBIN. Kinetic study on extraction process of Salvia miltiorrhiza: model establishment and key process parameters [J]. Chinese Journal of traditional Chinese Medicine, 2021, 46(03): 605\u201313."},{"issue":"1","key":"1968_CR59","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.1038\/s41598-017-02747-4","volume":"7","author":"L Xing","year":"2017","unstructured":"Xing L, Tan ZR, Cheng JL et al (2017) Bioavailability and pharmacokinetic comparison of tanshinones between two formulations of Salvia miltiorrhiza in healthy volunteers [J]. Sci Rep 7(1):4709","journal-title":"Sci Rep"},{"key":"1968_CR60","doi-asserted-by":"publisher","first-page":"554","DOI":"10.3389\/fphar.2019.00554","volume":"10","author":"X Meng","year":"2019","unstructured":"Meng X, Jiang J, Pan H et al (2019) Preclinical Absorption, Distribution, Metabolism, and Excretion of Sodium Danshensu, One of the Main Water-Soluble Ingredients in Salvia miltiorrhiza, in Rats. Front Pharmacol 10:554","journal-title":"Front Pharmacol"},{"issue":"Pt B","key":"1968_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117022","volume":"318","author":"J Huang","year":"2024","unstructured":"Huang J, Zhang J, Sun C et al (2024) Adjuvant role of Salvia miltiorrhiza bunge in cancer chemotherapy: A review of its bioactive components, health-promotion effect and mechanisms. J Ethnopharmacol 318(Pt B):117022","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"1968_CR62","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3390\/molecules21040456","volume":"21","author":"X Bi","year":"2016","unstructured":"Bi X, Liu X, Di L et al (2016) Improved oral bioavailability using a solid self-microemulsifying drug delivery system containing a multicomponent mixture extracted from Salvia miltiorrhiza. Molecules 21(4):456","journal-title":"Molecules"},{"issue":"2","key":"1968_CR63","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s13318-019-00597-1","volume":"45","author":"Y Jin","year":"2020","unstructured":"Jin Y, Yu L, Xu F et al (2020) Pharmacokinetics of active ingredients of Salvia miltiorrhiza and Carthamus tinctorius in compatibility in normal and cerebral ischemia rats: a comparative study. Eur J Drug Metab Pharmacokinet 45(2):273\u2013284","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"1","key":"1968_CR64","first-page":"59","volume":"17","author":"ME Xd","year":"2019","unstructured":"Xd ME, Cao YF, Che YY et al (2019) Danshen: a phytochemical and pharmacological overview. Chin J Nat Med 17(1):59\u201380","journal-title":"Chin J Nat Med"},{"issue":"3","key":"1968_CR65","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/j.jep.2011.08.007","volume":"137","author":"SH Lee","year":"2011","unstructured":"Lee SH, Kim YS, Lee SJ et al (2011) The protective effect of Salvia miltiorrhiza in an animal model of early experimentally induced diabetic nephropathy. J Ethnopharmacol 137(3):1409\u20131414","journal-title":"J Ethnopharmacol"},{"key":"1968_CR66","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.intimp.2016.06.024","volume":"38","author":"L Xu","year":"2016","unstructured":"Xu L, Shen P, Bi Y et al (2016) Danshen injection ameliorates STZ-induced diabetic nephropathy in association with suppression of oxidative stress, pro-inflammatory factors and fibrosis. Int Immunopharmacol 38:385\u201394","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"1968_CR67","first-page":"989","volume":"12","author":"X Liu","year":"2020","unstructured":"Liu X, Lu J, Liu S et al (2020) Huangqi-Danshen decoction alleviates diabetic nephropathy in db\/db mice by inhibiting PINK1\/Parkin-mediated mitophagy. Am J Transl Res 12(3):989\u2013998","journal-title":"Am J Transl Res"},{"issue":"1","key":"1968_CR68","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13020-024-00980-4","volume":"19","author":"C Li","year":"2024","unstructured":"Li C, Wen J, Zhan X et al (2024) Total tanshinones ameliorates cGAS-STING-mediated inflammatory and autoimmune diseases by affecting STING-IRF3 binding. Chin Med 19(1):107","journal-title":"Chin Med"},{"key":"1968_CR69","doi-asserted-by":"publisher","first-page":"155404","DOI":"10.1016\/j.phymed.2024.155404","volume":"128","author":"W Shi","year":"2024","unstructured":"Shi W, Xu G, Gao Y et al (2024) Compound Danshen Dripping Pill effectively alleviates cGAS-STING-triggered diseases by disrupting STING-TBK1 interaction. Phytomedicine 128:155404","journal-title":"Phytomedicine"},{"key":"1968_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.119364","volume":"342","author":"Y Peng","year":"2025","unstructured":"Peng Y, Wu S, Xu Y et al (2025) Huangqi-Danshen decoction alleviates renal fibrosis through targeting SCD1 to modulate cGAS\/STING signaling. J Ethnopharmacol 342:119364","journal-title":"J Ethnopharmacol"},{"key":"1968_CR71","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.abb.2014.12.012","volume":"566","author":"A Uruno","year":"2015","unstructured":"Uruno A, Yagishita Y, Yamamoto M (2015) The Keap1-Nrf2 system and diabetes mellitus. Arch Biochem Biophys 566:76\u201384","journal-title":"Arch Biochem Biophys"},{"issue":"7","key":"1968_CR72","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1142\/S0192415X17500781","volume":"45","author":"L An","year":"2017","unstructured":"An L, Zhou M, Marikar F et al (2017) Salvia miltiorrhiza lipophilic fraction attenuates oxidative stress in diabetic nephropathy through activation of nuclear factor erythroid 2-related factor 2. Am J Chin Med 45(7):1441\u20131457","journal-title":"Am J Chin Med"},{"issue":"6","key":"1968_CR73","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1159\/000489688","volume":"46","author":"R Liang","year":"2018","unstructured":"Liang R, Zhao Q, Jian G et al (2018) Tanshinone IIA attenuates contrast-induced nephropathy via Nrf2 activation in rats. Cell Physiol Biochem 46(6):2616\u20132623","journal-title":"Cell Physiol Biochem"},{"issue":"7","key":"1968_CR74","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1002\/tox.23511","volume":"37","author":"X Zhang","year":"2022","unstructured":"Zhang X, Long F, Li R et al (2022) Tanshinone IIA prevents acetaminophen-induced nephrotoxicity through the activation of the Nrf2-Mrp2\/4 pathway in mice. Environ Toxicol 37(7):1618\u20131628","journal-title":"Environ Toxicol"},{"issue":"8","key":"1968_CR75","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1142\/S0192415X22500914","volume":"50","author":"H Li","year":"2022","unstructured":"Li H, Wu M, Guo C et al (2022) Tanshinone IIA Regulates Keap1\/Nrf2 signal pathway by activating Sestrin2 to restrain pulmonary fibrosis. Am J Chin Med 50(8):2125\u20132151","journal-title":"Am J Chin Med"},{"issue":"Pt 3","key":"1968_CR76","doi-asserted-by":"publisher","first-page":"117356","DOI":"10.1016\/j.jep.2023.117356","volume":"319","author":"Z Xu","year":"2024","unstructured":"Xu Z, Cai K, Su SL et al (2024) Salvianolic acid B and tanshinone IIA synergistically improve early diabetic nephropathy through regulating PI3K\/Akt\/NF-kappaB signaling pathway. J Ethnopharmacol 319(Pt 3):117356","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"1968_CR77","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.intimp.2015.02.027","volume":"26","author":"DT Wang","year":"2015","unstructured":"Wang DT, Huang RH, Cheng X et al (2015) Tanshinone IIA attenuates renal fibrosis and inflammation via altering expression of TGF-beta\/Smad and NF-kappaB signaling pathway in 5\/6 nephrectomized rats. Int Immunopharmacol 26(1):4\u201312","journal-title":"Int Immunopharmacol"},{"issue":"1\u20132","key":"1968_CR78","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000452537","volume":"40","author":"JX Yang","year":"2016","unstructured":"Yang JX, Pan YY, Ge JH et al (2016) Tanshinone II A attenuates TNF-alpha-Induced Expression of VCAM-1 and ICAM-1 in endothelial progenitor cells by blocking activation of NF-kappaB. Cell Physiol Biochem 40(1\u20132):195\u2013206","journal-title":"Cell Physiol Biochem"},{"issue":"5","key":"1968_CR79","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.jdiacomp.2015.02.011","volume":"29","author":"JJ Liu","year":"2015","unstructured":"Liu JJ, Yeoh LY, Sum CF et al (2015) Vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1, is associated with diabetic kidney disease in Asians with type 2 diabetes. J Diabetes Complications 29(5):707\u2013712","journal-title":"J Diabetes Complications"},{"issue":"4","key":"1968_CR80","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.4037","volume":"42","author":"P Kaur","year":"2024","unstructured":"Kaur P, Dahiya R, Nandave M et al (2024) Unveiling the crucial role of intercellular adhesion molecule-1 in secondary diabetic complications. Cell Biochem Funct 42(4):e4037","journal-title":"Cell Biochem Funct"},{"issue":"4","key":"1968_CR81","doi-asserted-by":"publisher","first-page":"259","DOI":"10.5603\/FHC.a2021.0025","volume":"59","author":"J Zeng","year":"2021","unstructured":"Zeng J, Bao X (2021) Tanshinone IIA attenuates high glucose-induced epithelial-to-mesenchymal transition in HK-2 cells through VDR\/Wnt\/\u03b2-catenin signaling pathway. Folia Histochem Cytobiol 59(4):259\u2013270","journal-title":"Folia Histochem Cytobiol"},{"issue":"6","key":"1968_CR82","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.1007\/s00210-023-02853-3","volume":"397","author":"JY Zeng","year":"2024","unstructured":"Zeng JY, Wang Y, Hong FY et al (2024) Tanshinone IIA is superior to paricalcitol in ameliorating tubulointerstitial fibrosis through regulation of VDR\/Wnt\/\u03b2-catenin pathway in rats with diabetic nephropathy. Naunyn Schmiedebergs Arch Pharmacol 397(6):3959\u20133977","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"2","key":"1968_CR83","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.biocel.2012.09.017","volume":"45","author":"AP Lakshmanan","year":"2013","unstructured":"Lakshmanan AP, Harima M, Suzuki K et al (2013) The hyperglycemia stimulated myocardial endoplasmic reticulum (ER) stress contributes to diabetic cardiomyopathy in the transgenic non-obese type 2 diabetic rats: a differential role of unfolded protein response (UPR) signaling proteins. Int J Biochem Cell Biol 45(2):438\u2013447","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"1968_CR84","first-page":"267","volume":"9","author":"F Dadras","year":"2015","unstructured":"Dadras F, Khoshjou F (2015) Endoplasmic reticulum and its role in diabetic nephropathy. Iran J Kidney Dis 9(4):267\u2013272","journal-title":"Iran J Kidney Dis"},{"issue":"10","key":"1968_CR85","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/s41419-018-0985-z","volume":"9","author":"Y He","year":"2018","unstructured":"He Y, Zhang M, Wu Y et al (2018) Aberrant activation of Notch-1 signaling inhibits podocyte restoration after islet transplantation in a rat model of diabetic nephropathy. Cell Death Dis 9(10):950","journal-title":"Cell Death Dis"},{"issue":"9","key":"1968_CR86","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.yexcr.2012.02.036","volume":"318","author":"R Bonegio","year":"2012","unstructured":"Bonegio R, Susztak K (2012) Notch signaling in diabetic nephropathy. Exp Cell Res 318(9):986\u2013992","journal-title":"Exp Cell Res"},{"issue":"4","key":"1968_CR87","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.bbrc.2018.02.187","volume":"497","author":"X Liu","year":"2018","unstructured":"Liu X, Zhang Y, Shi M et al (2018) Notch1 regulates PTEN expression to exacerbate renal tubulointerstitial fibrosis in diabetic nephropathy by inhibiting autophagy via interactions with Hes1. Biochem Biophys Res Commun 497(4):1110\u20131116","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"1968_CR88","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.1002\/fsn3.2998","volume":"10","author":"L Zhang","year":"2022","unstructured":"Zhang L, Yang F (2022) Tanshinone IIA improves diabetes-induced renal fibrosis by regulating the miR-34-5p\/Notch1 axis. Food Sci Nutr 10(11):4019\u20134040","journal-title":"Food Sci Nutr"},{"issue":"10","key":"1968_CR89","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1021\/acs.chemrestox.9b00117","volume":"32","author":"W Li","year":"2019","unstructured":"Li W, Sargsyan D, Wu R et al (2019) DNA methylome and transcriptome alterations in high glucose-induced diabetic nephropathy cellular model and identification of novel targets for treatment by Tanshinone IIA. Chem Res Toxicol 32(10):1977\u20131988","journal-title":"Chem Res Toxicol"},{"issue":"5","key":"1968_CR90","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/aps.2017.193","volume":"39","author":"ZM Li","year":"2018","unstructured":"Li ZM, Xu SW, Liu PQ (2018) Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics [J]. Acta Pharmacol Sin 39(5):802\u2013824","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"1968_CR91","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1016\/j.bbagen.2013.01.008","volume":"1830","author":"LL Pan","year":"2013","unstructured":"Pan LL, Liu XH, Jia YL et al (2013) A novel compound derived from danshensu inhibits apoptosis via upregulation of heme oxygenase-1 expression in SH-SY5Y cells. Biochim Biophys Acta 1830(4):2861\u20132871","journal-title":"Biochim Biophys Acta"},{"key":"1968_CR92","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8267560","volume":"2018","author":"L Gao","year":"2018","unstructured":"Gao L, Kwan YW, Bulmer AC et al (2018) Noninvasive real-time characterization of renal clearance kinetics in diabetic mice after receiving Danshensu treatment. Oxid Med Cell Longev 2018:8267560","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"1968_CR93","doi-asserted-by":"publisher","first-page":"536","DOI":"10.4062\/biomolther.2015.191","volume":"24","author":"Y Chen","year":"2016","unstructured":"Chen Y, Liu Z, Zhou F et al (2016) Evaluating pharmacological effects of two major components of Shuangdan oral liquid: role of Danshensu and Paeonol in diabetic nephropathy rat. Biomol Ther (Seoul) 24(5):536\u2013542","journal-title":"Biomol Ther (Seoul)"},{"key":"1968_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154271","volume":"104","author":"Y Xue","year":"2022","unstructured":"Xue Y, Zhang L, Zhang L et al (2022) Danshensu prevents thrombosis by inhibiting platelet activation via SIRT1\/ROS\/mtDNA pathways without increasing bleeding risk. Phytomedicine 104:154271","journal-title":"Phytomedicine"},{"issue":"1","key":"1968_CR95","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3892\/ijmm.2016.2584","volume":"38","author":"T Hu","year":"2016","unstructured":"Hu T, Wei G, Xi M et al (2016) Synergistic cardioprotective effects of Danshensu and hydroxysafflor yellow A against myocardial ischemia-reperfusion injury are mediated through the Akt\/Nrf2\/HO-1 pathway. Int J Mol Med 38(1):83\u201394","journal-title":"Int J Mol Med"},{"key":"1968_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/srep23693","volume":"6","author":"H Li","year":"2016","unstructured":"Li H, Song F, Duan LR et al (2016) Paeonol and danshensu combination attenuates apoptosis in myocardial infarcted rats by inhibiting oxidative stress: roles of Nrf2\/HO-1 and PI3K\/Akt pathway. Sci Rep 6:23693","journal-title":"Sci Rep"},{"key":"1968_CR97","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3389\/fphar.2020.00851","volume":"11","author":"Y Shen","year":"2020","unstructured":"Shen Y, Wang S, Liu Y et al (2020) The effects of salvianolate combined with western medicine on diabetic nephropathy: a systematic review and meta-analysis. Front Pharmacol 11:851","journal-title":"Front Pharmacol"},{"issue":"5","key":"1968_CR98","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1139\/cjpp-2023-0089","volume":"102","author":"Y Wang","year":"2024","unstructured":"Wang Y, Chang J, Qiao S et al (2024) Salvianolic acid B attenuates diabetic nephropathy through alleviating ADORA2B, NALP3 in flammasome, and NFkappaB activity. Can J Physiol Pharmacol 102(5):318\u2013330","journal-title":"Can J Physiol Pharmacol"},{"issue":"1","key":"1968_CR99","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1159\/000534832","volume":"48","author":"F Wen","year":"2023","unstructured":"Wen F, Zhang S, Sun L et al (2023) Salvianolic acid B inhibits oxidative stress in glomerular mesangial cells alleviating diabetic nephropathy by regulating SIRT3\/FOXO1 signaling. Kidney Blood Press Res 48(1):738\u2013751","journal-title":"Kidney Blood Press Res"},{"issue":"42","key":"1968_CR100","doi-asserted-by":"publisher","first-page":"e35613","DOI":"10.1097\/MD.0000000000035613","volume":"102","author":"S He","year":"2023","unstructured":"He S, Yao L, Li J (2023) Role of MCP-1\/CCR2 axis in renal fibrosis: mechanisms and therapeutic targeting. Medicine (Baltimore) 102(42):e35613","journal-title":"Medicine (Baltimore)"},{"issue":"1\u20133","key":"1968_CR101","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ejphar.2007.10.070","volume":"579","author":"ES Kang","year":"2008","unstructured":"Kang ES, Lee GT, Kim BS et al (2008) Lithospermic acid B ameliorates the development of diabetic nephropathy in OLETF rats. Eur J Pharmacol 579(1\u20133):418\u2013425","journal-title":"Eur J Pharmacol"},{"issue":"16","key":"1968_CR102","first-page":"3922","volume":"45","author":"L Sun","year":"2020","unstructured":"Sun L, Tian PP, Zhang F et al (2020) Effect of salvianolic acid B on high-glucose induced renal tubular epithelial-mesenchymal transition in rats and its mechanism. Zhongguo Zhong Yao Za Zhi 45(16):3922\u20133930","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"6","key":"1968_CR103","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x20175954","volume":"50","author":"ZG Ma","year":"2017","unstructured":"Ma ZG, Xia HQ, Cui SL et al (2017) Attenuation of renal ischemic reperfusion injury by salvianolic acid B via suppressing oxidative stress and inflammation through PI3K\/Akt signaling pathway. Braz J Med Biol Res 50(6):e5954","journal-title":"Braz J Med Biol Res"},{"issue":"7","key":"1968_CR104","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1248\/bpb.31.1381","volume":"31","author":"P Luo","year":"2008","unstructured":"Luo P, Tan Z, Zhang Z et al (2008) Inhibitory effects of salvianolic acid B on the high glucose-induced mesangial proliferation via NF-kappaB-dependent pathway. Biol Pharm Bull 31(7):1381\u20131386","journal-title":"Biol Pharm Bull"},{"issue":"2","key":"1968_CR105","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim J, Kundu M, Viollet B et al (2011) AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 13(2):132\u2013141","journal-title":"Nat Cell Biol"},{"issue":"5","key":"1968_CR106","doi-asserted-by":"publisher","first-page":"13956","DOI":"10.1080\/21655979.2022.2083822","volume":"13","author":"J Chen","year":"2022","unstructured":"Chen J, Hu Q, Luo Y et al (2022) Salvianolic acid B attenuates membranous nephropathy by activating renal autophagy via microRNA-145-5p\/phosphatidylinositol 3-kinase\/AKT pathway. Bioengineered 13(5):13956\u201313969","journal-title":"Bioengineered"},{"issue":"9","key":"1968_CR107","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/0006-2952(96)00067-6","volume":"51","author":"TJ Lin","year":"1996","unstructured":"Lin TJ, Zhang KJ, Liu GT (1996) Effects of salvianolic acid A on oxygen radicals released by rat neutrophils and on neutrophil function. Biochem Pharmacol 51(9):1237\u20131241","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"1968_CR108","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.bbrc.2012.04.021","volume":"421","author":"HA Zhang","year":"2012","unstructured":"Zhang HA, Gao M, Zhang L et al (2012) Salvianolic acid A protects human SH-SY5Y neuroblastoma cells against H(2)O(2)-induced injury by increasing stress tolerance ability. Biochem Biophys Res Commun 421(3):479\u2013483","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"1968_CR109","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1124\/dmd.113.053694","volume":"42","author":"H Xu","year":"2014","unstructured":"Xu H, Li Y, Che X et al (2014) Metabolism of salvianolic acid A and antioxidant activities of its methylated metabolites. Drug Metab Dispos 42(2):274\u2013281","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"1968_CR110","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1016\/j.thromres.2010.04.006","volume":"126","author":"HY Fan","year":"2010","unstructured":"Fan HY, Fu FH, Yang MY et al (2010) Antiplatelet and antithrombotic activities of salvianolic acid A. Thromb Res 126(1):e17-22","journal-title":"Thromb Res"},{"issue":"6","key":"1968_CR111","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1111\/j.1538-7836.2010.03859.x","volume":"8","author":"ZS Huang","year":"2010","unstructured":"Huang ZS, Zeng CL, Zhu LJ et al (2010) Salvianolic acid A inhibits platelet activation and arterial thrombosis via inhibition of phosphoinositide 3-kinase. J Thromb Haemost 8(6):1383\u20131393","journal-title":"J Thromb Haemost"},{"issue":"6","key":"1968_CR112","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1159\/000486154","volume":"44","author":"B Hou","year":"2017","unstructured":"Hou B, Qiang G, Zhao Y et al (2017) Salvianolic acid a protects against diabetic nephropathy through ameliorating glomerular endothelial dysfunction via inhibiting AGE-RAGE Signaling. Cell Physiol Biochem 44(6):2378\u20132394","journal-title":"Cell Physiol Biochem"},{"key":"1968_CR113","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.freeradbiomed.2014.01.025","volume":"69","author":"H Zhang","year":"2014","unstructured":"Zhang H, Liu YY, Jiang Q et al (2014) Salvianolic acid A protects RPE cells against oxidative stress through activation of Nrf2\/HO-1 signaling. Free Radic Biol Med 69:219\u201328","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"1968_CR114","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13098-022-00868-z","volume":"14","author":"X Wang","year":"2022","unstructured":"Wang X, Sun X, Abulizi A et al (2022) Effects of salvianolic acid A on intestinal microbiota and lipid metabolism disorders in Zucker diabetic fatty rats. Diabetol Metab Syndr 14(1):135","journal-title":"Diabetol Metab Syndr"},{"issue":"3","key":"1968_CR115","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/nrendo.2015.218","volume":"12","author":"M Knip","year":"2016","unstructured":"Knip M, Siljander H (2016) The role of the intestinal microbiota in type 1 diabetes mellitus. Nat Rev Endocrinol 12(3):154\u2013167","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"1968_CR116","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/mi.2016.42","volume":"10","author":"JY Yang","year":"2017","unstructured":"Yang JY, Lee YS, Kim Y et al (2017) Gut commensal Bacteroides acidifaciens prevents obesity and improves insulin sensitivity in mice. Mucosal Immunol 10(1):104\u2013116","journal-title":"Mucosal Immunol"},{"key":"1968_CR117","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5516035","volume":"2021","author":"M Chi","year":"2021","unstructured":"Chi M, Ma K, Wang J et al (2021) The immunomodulatory effect of the gut microbiota in kidney disease. J Immunol Res 2021:5516035","journal-title":"J Immunol Res"},{"issue":"6","key":"1968_CR118","first-page":"549","volume":"17","author":"A Bomzon","year":"1997","unstructured":"Bomzon A, Holt S, Moore K (1997) Bile acids, oxidative stress, and renal function in biliary obstruction. Semin Nephrol 17(6):549\u2013562","journal-title":"Semin Nephrol"},{"issue":"4","key":"1968_CR119","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41401-018-0029-3","volume":"40","author":"J Zhao","year":"2019","unstructured":"Zhao J, Zhang QL, Shen JH et al (2019) Magnesium lithospermate B improves the gut microbiome and bile acid metabolic profiles in a mouse model of diabetic nephropathy. Acta Pharmacol Sin 40(4):507\u2013513","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"1968_CR120","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1055\/s-2004-815490","volume":"70","author":"Y Zhang","year":"2004","unstructured":"Zhang Y, Akao T, Nakamura N et al (2004) Extremely low bioavailability of magnesium lithospermate B, an active component from Salvia miltiorrhiza, in rat [J]. Planta Med 70(2):138\u2013142","journal-title":"Planta Med"},{"issue":"3","key":"1968_CR121","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/01.ASN.0000051660.82593.19","volume":"14","author":"GT Lee","year":"2003","unstructured":"Lee GT, Ha H, Jung M et al (2003) Delayed treatment with lithospermate B attenuates experimental diabetic renal injury. J Am Soc Nephrol 14(3):709\u2013720","journal-title":"J Am Soc Nephrol"},{"issue":"42","key":"1968_CR122","doi-asserted-by":"publisher","first-page":"26625","DOI":"10.18632\/oncotarget.23803","volume":"9","author":"W Wang","year":"2018","unstructured":"Wang W, Zhou PH, Hu W et al (2018) Cryptotanshinone hinders renal fibrosis and epithelial transdifferentiation in obstructive nephropathy by inhibiting TGF-beta1\/Smad3\/integrin beta1 signal. Oncotarget 9(42):26625\u201326637","journal-title":"Oncotarget"},{"issue":"8","key":"1968_CR123","doi-asserted-by":"publisher","first-page":"13354","DOI":"10.1002\/jcb.28609","volume":"120","author":"R Zhu","year":"2019","unstructured":"Zhu R, Wang W, Yang S (2019) Cryptotanshinone inhibits hypoxia\/reoxygenation-induced oxidative stress and apoptosis in renal tubular epithelial cells. J Cell Biochem 120(8):13354\u201313360","journal-title":"J Cell Biochem"},{"key":"1968_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104307","volume":"147","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Lu W, Zhang X et al (2019) Cryptotanshinone protects against pulmonary fibrosis through inhibiting Smad and STAT3 signaling pathways. Pharmacol Res 147:104307","journal-title":"Pharmacol Res"},{"issue":"2","key":"1968_CR125","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10753-010-9214-3","volume":"34","author":"S Tang","year":"2011","unstructured":"Tang S, Shen XY, Huang HQ et al (2011) Cryptotanshinone suppressed inflammatory cytokines secretion in RAW264.7 macrophages through inhibition of the NF-kappaB and MAPK signaling pathways. Inflammation 34(2):111\u20138","journal-title":"Inflammation"},{"issue":"2","key":"1968_CR126","doi-asserted-by":"publisher","first-page":"63","DOI":"10.15430\/JCP.2018.23.2.63","volume":"23","author":"JY Hong","year":"2018","unstructured":"Hong JY, Park SH, Park HJ et al (2018) Anti-proliferative effect of 15,16-dihydrotanshinone I through cell cycle arrest and the regulation of AMP-activated protein kinase\/Akt\/mTOR and mitogen-activated protein kinase signaling pathway in human hepatocellular carcinoma cells. J Cancer Prev 23(2):63\u201369","journal-title":"J Cancer Prev"},{"key":"1968_CR127","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.freeradbiomed.2022.01.015","volume":"180","author":"C Sun","year":"2022","unstructured":"Sun C, Han B, Zhai Y et al (2022) Dihydrotanshinone I inhibits ovarian tumor growth by activating oxidative stress through Keap1-mediated Nrf2 ubiquitination degradation. Free Radic Biol Med 180:220\u2013235","journal-title":"Free Radic Biol Med"},{"key":"1968_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155661","volume":"129","author":"Z Li","year":"2024","unstructured":"Li Z, Mo RL, Gong JF et al (2024) Dihydrotanshinone I inhibits gallbladder cancer growth by targeting the Keap1-Nrf2 signaling pathway and Nrf2 phosphorylation. Phytomedicine 129:155661","journal-title":"Phytomedicine"},{"issue":"9","key":"1968_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpet.2025.103655","volume":"392","author":"R Mahendran","year":"2025","unstructured":"Mahendran R, Lim SK, Ong KC et al (2025) Antiproliferative effects of dihydrotanshinone I on autosomal dominant polycystic kidney disease via immunomodulation. J Pharmacol Exp Ther 392(9):103655","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"1968_CR130","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.bbadis.2017.12.033","volume":"1864","author":"Y Yang","year":"2018","unstructured":"Yang Y, Li X, Peng L et al (2018) Tanshindiol C inhibits oxidized low-density lipoprotein induced macrophage foam cell formation via a peroxiredoxin 1 dependent pathway. Biochimica et Biophysica Acta (BBA) 1864(3):882\u2013890","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"1968_CR131","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28041990","author":"Z Chen","year":"2023","unstructured":"Chen Z, Feng H, Peng C et al (2023) Renoprotective effects of Tanshinone IIA: a literature review. Molecules. https:\/\/doi.org\/10.3390\/molecules28041990","journal-title":"Molecules"},{"key":"1968_CR132","doi-asserted-by":"publisher","first-page":"872085","DOI":"10.3389\/fphar.2022.872085","volume":"13","author":"H Zhao","year":"2022","unstructured":"Zhao H, Han B, Li X et al (2022) Salvia miltiorrhiza in breast cancer treatment: a review of its phytochemistry, derivatives, nanoparticles, and potential mechanisms. Front Pharmacol 13:872085","journal-title":"Front Pharmacol"},{"key":"1968_CR133","volume":"2022","author":"W Zhang","year":"2022","unstructured":"Zhang W, Li J, Yang P et al (2022) Efficacy and safety of Salvia miltiorrhiza for treating chronic kidney diseases: a systematic review and meta-analysis. Evid Based Complement Alternat Med 2022:2117433","journal-title":"Evid Based Complement Alternat Med"},{"key":"1968_CR134","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/539185","volume":"2015","author":"D Luo","year":"2015","unstructured":"Luo D, Qin Y, Yuan W et al (2015) Compound danshen dripping pill for treating early diabetic retinopathy: a randomized, double-dummy, double-blind study. Evid Based Complement Alternat Med 2015:539185","journal-title":"Evid Based Complement Alternat Med"},{"issue":"4","key":"1968_CR135","first-page":"3405","volume":"16","author":"JM Nie","year":"2018","unstructured":"Nie JM, Li HF (2018) Therapeutic effects of Salvia miltiorrhiza injection combined with telmisartan in patients with diabetic nephropathy by influencing collagen IV and fibronectin: a case-control study. Exp Ther Med 16(4):3405\u20133412","journal-title":"Exp Ther Med"},{"issue":"8","key":"1968_CR136","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000035853","volume":"103","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Luo L, Li X et al (2024) The effects of Salvia miltiorrhiza and ligustrazine injection combined with ACEI\/ARB on diabetic kidney disease: a systematic review and meta-analysis. Medicine (Baltimore) 103(8):e35853","journal-title":"Medicine (Baltimore)"},{"key":"1968_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153873","volume":"95","author":"YC Chen","year":"2022","unstructured":"Chen YC, Chen HT, Yeh CC et al (2022) Four prescribed Chinese herbal medicines provide renoprotection and survival benefit without hyperkalemia risk in patients with advanced chronic kidney disease: a nationwide cohort study. Phytomedicine 95:153873","journal-title":"Phytomedicine"},{"issue":"5","key":"1968_CR138","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/j.2042-7158.1995.tb05819.x","volume":"47","author":"K Chan","year":"1995","unstructured":"Chan K, Lo AC, Yeung JH et al (1995) The effects of Danshen (Salvia miltiorrhiza) on warfarin pharmacodynamics and pharmacokinetics of warfarin enantiomers in rats. J Pharm Pharmacol 47(5):402\u2013406","journal-title":"J Pharm Pharmacol"},{"issue":"4","key":"1968_CR139","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1345\/aph.19029","volume":"35","author":"TY Chan","year":"2001","unstructured":"Chan TY (2001) Interaction between warfarin and danshen (Salvia miltiorrhiza) [j]. Ann Pharmacother 35(4):501\u2013504","journal-title":"Ann Pharmacother"},{"issue":"1","key":"1968_CR140","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1515\/dmdi-2011-0038","volume":"27","author":"X Zhou","year":"2012","unstructured":"Zhou X, Chan K, Yeung JH (2012) Herb-drug interactions with Danshen (Salvia miltiorrhiza): a review on the role of cytochrome P450 enzymes. Drug Metab Drug Interact 27(1):9\u201318","journal-title":"Drug Metab Drug Interact"},{"key":"1968_CR141","doi-asserted-by":"publisher","first-page":"950525","DOI":"10.3389\/fphar.2022.950525","volume":"13","author":"X Wang","year":"2022","unstructured":"Wang X, Fa J, Zhang Y et al (2022) Evaluation of Herb-Drug Interaction Between Danshen and Rivaroxaban in Rat and Human Liver Microsomes. Front Pharmacol 13:950525","journal-title":"Front Pharmacol"},{"key":"1968_CR142","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/1520132","volume":"2023","author":"SK Dubey","year":"2023","unstructured":"Dubey SK, Rai SN, Singh VK et al (2023) Evaluation of pleurotus mushroom effects on histopathological changes in organs of diabetic rats. Dis Markers 2023:1520132","journal-title":"Dis Markers"},{"key":"1968_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.119885","volume":"348","author":"K Cai","year":"2025","unstructured":"Cai K, Xu Z, Huang SR et al (2025) Absorption and metabolic transformation mechanisms of the interaction between salvianolic acids and tanshinones in DKD rats. J Ethnopharmacol 348:119885","journal-title":"J Ethnopharmacol"},{"issue":"5","key":"1968_CR144","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/aps.2010.27","volume":"31","author":"BB Chang","year":"2010","unstructured":"Chang BB, Zhang L, Cao WW et al (2010) Pharmacokinetic interactions induced by content variation of major water-soluble components of Danshen preparation in rats. Acta Pharmacol Sin 31(5):638\u2013646","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"1968_CR145","first-page":"247","volume":"18","author":"Y Gao","year":"1998","unstructured":"Gao Y, Lu R, Wang X et al (1998) A clinical trial of tang shen ning for treatment of diabetic nephropathy. J Tradit Chin Med 18(4):247\u2013252","journal-title":"J Tradit Chin Med"},{"key":"1968_CR146","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.phrs.2018.10.030","volume":"139","author":"X Xiang","year":"2019","unstructured":"Xiang X, Cai HD, Su SL et al (2019) Salvia miltiorrhiza protects against diabetic nephropathy through metabolome regulation and wnt\/beta-catenin and TGF-beta signaling inhibition. Pharmacol Res 139:26\u201340","journal-title":"Pharmacol Res"},{"issue":"11","key":"1968_CR147","first-page":"2595","volume":"45","author":"B Zhang","year":"2020","unstructured":"Zhang B, Zhang XL, Zhang CY et al (2020) Effect of Guanxin Danshen Formulation on diabetic kidney disease in db\/db mice through regulation of Nrf2 pathway. Zhongguo Zhong Yao Za Zhi 45(11):2595\u20132600","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"6","key":"1968_CR148","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3275\/8763","volume":"36","author":"P Chen","year":"2013","unstructured":"Chen P, Chen J, Zheng Q et al (2013) Pioglitazone, extract of compound Danshen dripping pill, and quercetin ameliorate diabetic nephropathy in diabetic rats. J Endocrinol Invest 36(6):422\u2013427","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"1968_CR149","first-page":"953","volume":"36","author":"JJ Yin","year":"2013","unstructured":"Yin JJ, Yang Y, Wang QB et al (2013) Effect of chinese herbal medicine with supplement qi and activating blood circulation on tubular reabsorption function of diabetic nephropathy rats. Zhong Yao Cai 36(6):953\u2013958","journal-title":"Zhong Yao Cai"},{"issue":"2","key":"1968_CR150","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1248\/bpb.32.220","volume":"32","author":"SK Kim","year":"2009","unstructured":"Kim SK, Jung KH, Lee BC (2009) Protective effect of Tanshinone IIA on the early stage of experimental diabetic nephropathy. Biol Pharm Bull 32(2):220\u2013224","journal-title":"Biol Pharm Bull"},{"issue":"5","key":"1968_CR151","doi-asserted-by":"publisher","first-page":"12224","DOI":"10.1080\/21655979.2022.2074619","volume":"13","author":"Y Li","year":"2022","unstructured":"Li Y, Deng X, Zhuang W et al (2022) Tanshinone IIA down-regulates -transforming growth factor beta 1 to relieve renal tubular epithelial cell inflammation and pyroptosis caused by high glucose. Bioengineered 13(5):12224\u201312236","journal-title":"Bioengineered"}],"updated-by":[{"DOI":"10.1007\/s11418-026-02064-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000}}],"container-title":["Journal of Natural Medicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-025-01968-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11418-025-01968-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-025-01968-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T07:02:33Z","timestamp":1786431753000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11418-025-01968-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":151,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1968"],"URL":"https:\/\/doi.org\/10.1007\/s11418-025-01968-6","relation":{},"ISSN":["1340-3443","1861-0293"],"issn-type":[{"value":"1340-3443","type":"print"},{"value":"1861-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"10 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: A paragraph under the sub section \u201ccGAS-STING pathway\u201d is added.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11418-026-02064-z","URL":"https:\/\/doi.org\/10.1007\/s11418-026-02064-z","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}